Back to briefing
Research United States

Deep Learning Diagnostic and Risk-stratification for IPF and COPD

Idiopathic pulmonary fibrosis, non‑specific interstitial pneumonia, and chronic obstructive pulmonary disease are severe, progressive, irreversible pulmonary disorders with modest therapeutic response and poor prognosis. Prompt and accurate diagnosis is essential to enable early care that can delay disease progression and prolong survival. Artificial intelligence–assisted digital lung auscultation and deep‑learning automation of lung ultrasound offer alternative, objective methods for earlier diagnosis of these conditions.

Published
8 Apr 2022
2 min read 1 source
Intelligence brief
United States / Research
CH

Idiopathic pulmonary fibrosis, non‑specific interstitial pneumonia, and chronic obstructive pulmonary disease are severe, progressive, irreversible pulmonary disorders with modest therapeutic response and poor prognosis. Prompt and accurate diagnosis is essential to enable early care that can delay disease progression and prolong survival. Artificial intelligence–assisted digital lung auscultation and deep‑learning automation of lung ultrasound offer alternative, objective methods for earlier diagnosis of these conditions.

Why it matters

The study illustrates how AI can enhance pulmonary diagnostics, supporting Swiss AI efforts to improve medical imaging and patient care.

Primary source record
ClinicalTrials.gov

Original source record. Open the original record to verify the underlying announcement.

Your privacy choices

Allow optional Google Analytics to help us understand how the site is used. Analytics stays off unless you accept. Privacy details